한글목차

세계의 바이오포토닉스 시장은 2030년까지 2,275억 달러에 이를 전망

2023년에 1,108억 달러로 평가된 세계의 바이오포토닉스 시장은 2030년에는 2,275억 달러에 이를 전망이며, 분석 기간 2023년부터 2030년까지 CAGR은 10.8%로 성장할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 시스루 이미징 용도는 CAGR 0.1%로 성장을 지속하고, 분석 기간이 끝날 때 341억 달러에 달할 것으로 예측됩니다. 인사이드 이미징 용도 부문의 성장률은 분석 기간 동안 CAGR 8.8%로 추정됩니다.

미국 시장은 301억 달러로 추정, 중국은 CAGR 10.3%로 성장 예측

미국의 바이오포토닉스 시장은 2023년 301억 달러로 평가되었습니다. 세계 2위 경제대국인 중국은 2030년까지 353억 달러 규모에 이를 것으로 예측되며, 분석 기간 2023년부터 2030년까지 CAGR은 10.3%로 전망됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 9.2%와 9.1%로 예측되고 있습니다. 유럽에서는 독일이 CAGR 약 9.3%로 성장할 것으로 예측됩니다.

세계 바이오포토닉스 시장-동향 및 촉진요인 정리

바이오포토닉스는 생물학과 포토닉스의 교차점으로 과학자가 빛을 이용하여 분자에서 세포, 조직까지 생물학적 물질을 탐색하고 조작하는 방법에 혁명을 가져오고 있습니다. 이 분야는 흡수, 산란, 발광에 의한 빛의 상호 작용을 이용하여 미세한 수준에서 생명을 연구할 수 있다는 기본 원리에 근거합니다. 바이오포토닉스의 역사는 광학 현미경의 발명으로 거슬러 올라갈 수 있습니다. 초해상 형광현미경과 같은 현대적인 진보는 세포 이미징의 한계를 크게 넓혀 연구자들은 10나노미터까지의 구조를 볼 수 있게 되었습니다. 바이오포토닉스의 진화는 이미징과 분석 기술의 차원, 해상도, 감도, 특이성의 향상에 의해 현저하고, 실시간으로 현장에서 분석을 제공하는 포인트 오브 케어 기기의 요구 증가에 의해 박차가 걸려 있습니다.

임상과 환경에서 바이오포토닉스는 매우 유용합니다. 내시경 검사, 유동 세포 계측법, 형광 in situ 하이브리드 화(FISH)와 같은 기술은 암 진단에 매우 중요하며 안과에서는 광 간섭 단층계(OCT) 및 라식과 같은 기술 혁신이 환자의 결과를 바꾸고 있습니다. 제약 분야에서도 의약 공정에서 매우 중요한 다중 파라미터 형광 검출을 이용한 고 처리량 스크리닝 방법의 혜택을 누리고 있습니다. 의료에 머무르지 않고, 바이오포토닉스는 환경 모니터링과 농업에도 이르렀으며, 머신러닝과 통합된 광학 센서가 생산성과 지속가능성을 크게 향상시키고 있습니다. 이 기술의 다양한 응용은 다양한 공간적 및 시간적 스케일로 동작하는 능력, 저침습성, 다른 기술과의 호환성에 의해 추진되어 과학 연구나 실용적인 응용에 있어서 만능적인 툴이 되고 있습니다.

바이오포토닉스의 성장에는 몇 가지 중요한 요인이 있습니다. 이미징 및 센싱 기술의 발전은 해상도 향상과 조직에 대한 깊은 침투를 실현하며 복잡한 생물학적 조사에 필수적입니다. 인공지능의 통합은 데이터 분석을 향상시켜 바이오포토닉스를 보다 효율적이고 널리 적용할 수 있도록 합니다. OCT와 같은 기술은 안전과 편의성에서 선호되고 있으며, 비침습 의료 치료에 대한 소비자 수요도 증가하고 있습니다. 게다가 바이오포토닉 디바이스의 규제 승인과 표준화는 안전성과 효능을 확보하고 임상 현장에서의 채용을 촉진하고 있습니다. 학계, 연구실, 산업계의 협업은 기술 혁신에 필수적이며 바이오포토닉 기술의 개발과 상업화를 가속화하고 있습니다. 개인화된 의료가 중요해지면 진단 및 치료 옵션을 맞춤화하는 데 중요한 역할을 하기 때문에 바이오포토닉스 수요가 더욱 높아집니다. 기존의 의료 분야뿐만 아니라 환경과 식품의 안전성에도 응용이 확산됨에 따라 바이오포토닉스의 가능성은 계속 확대되고 바이오 포토닉 기술의 인지도와 채용률을 높이는 교육 훈련 프로그램 증가로 그 중요성이 강조되었습니다.

조사 대상 기업 예(총 83건)

• F. Hoffmann-La Roche AG
• GE Healthcare
• Horiba Ltd.
• IDEX Corporation
• IPG Photonics Corporation
• Koninklijke Philips NV
• Procter & Gamble Company, The
• Qiagen, Inc.

목차

제1장 조사 방법

제2장 주요 요약

• 시장 개요
• 주요 기업
• 시장 동향 및 촉진요인
• 세계 시장 전망

제3장 시장 분석

• 미국
• 캐나다
• 일본
• 중국
• 유럽
• 프랑스
• 독일
• 이탈리아
• 영국
• 기타 유럽
• 아시아태평양
• 세계 기타 지역

제4장 경쟁

영문목차

Global Biophotonics Market to Reach US$227.5 Billion by 2030

The global market for Biophotonics estimated at US$110.8 Billion in the year 2023, is expected to reach US$227.5 Billion by 2030, growing at a CAGR of 10.8% over the analysis period 2023-2030. See-through Imaging Application, one of the segments analyzed in the report, is expected to record a 0.1% CAGR and reach US$34.1 Billion by the end of the analysis period. Growth in the Inside Imaging Application segment is estimated at 8.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$30.1 Billion While China is Forecast to Grow at 10.3% CAGR

The Biophotonics market in the U.S. is estimated at US$30.1 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$35.3 Billion by the year 2030 trailing a CAGR of 10.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.2% and 9.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.3% CAGR.

Global Biophotonics Market - Key Trends and Drivers Summarized

Biophotonics, an intersection of biology and photonics, is revolutionizing how scientists explore and manipulate biological materials—from molecules to cells and tissues—using light. This field builds on the fundamental principle that light interactions, through absorption, scattering, or emission, can be harnessed to study life at microscopic levels. The history of biophotonics can be traced back to the invention of the optical microscope, which first allowed the detailed visual exploration of biological tissues. Modern advancements, such as super-resolution fluorescence microscopy, have significantly pushed the boundaries of cellular imaging, allowing researchers to view structures down to 10 nanometers. The evolution of biophotonics has been marked by enhancements in dimensionality, resolution, sensitivity, and specificity of imaging and analysis techniques, spurred by the growing need for point-of-care devices that offer real-time, in-field analysis.

In clinical and environmental settings, biophotonics is proving invaluable. Techniques like endoscopy, flow cytometry, and fluorescence in situ hybridization (FISH) are pivotal in cancer diagnostics, while in ophthalmology, innovations like Optical Coherence Tomography (OCT) and LASIK are transforming patient outcomes. The pharmaceutical field also benefits from high-throughput screening methods that utilize multiparameter fluorescence detection, crucial in the drug discovery process. Beyond medicine, biophotonics extends to environmental monitoring and agriculture, where optical sensors integrated with machine learning significantly enhance productivity and sustainability. This technology’s diverse applications are driven by its ability to operate across various spatial and temporal scales, its minimally invasive nature, and its compatibility with other technologies, making it a versatile tool in scientific research and practical applications.

The growth of biophotonics is fueled by several key factors. Advances in imaging and sensing technologies, which offer enhanced resolution and deeper tissue penetration, are crucial for complex biological investigations. The integration of artificial intelligence improves data analysis, making biophotonics more efficient and widely applicable. Consumer demand for non-invasive medical procedures is also increasing, as technologies like OCT become preferred for their safety and convenience. Additionally, regulatory approvals and standardization across biophotonic devices ensure their safety and efficacy, encouraging their adoption in clinical settings. Collaborations between academia, research labs, and industry are vital for innovation, speeding up the development and commercialization of biophotonic technologies. The growing emphasis on personalized medicine further drives the demand for biophotonics, as it plays a critical role in enabling customized diagnostic and treatment options. As applications expand beyond traditional medical fields into environmental and food safety, the potential for biophotonics continues to grow, underscored by increased educational and training programs that raise awareness and adoption of biophotonic technologies.

Select Competitors (Total 83 Featured) -

• F. Hoffmann-La Roche AG
• GE Healthcare
• Horiba Ltd.
• IDEX Corporation
• IPG Photonics Corporation
• Koninklijke Philips NV
• Procter & Gamble Company, The
• Qiagen, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Global Economic Update
  • Biophotonics - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Increasing Demand for Non-Invasive Diagnostic Techniques Throws the Spotlight on Biophotonics
  • Advances in Optical Technologies Propel Growth in the Biophotonics Market
  • Rising Adoption of Biophotonics in Medical Imaging Drives Market Expansion
  • Expanding Applications in Oncology Expands Addressable Market Opportunity
  • Innovations in Light-Based Therapies Generate Demand for Advanced Biophotonics Solutions
  • Increasing Focus on Personalized Medicine Accelerates Demand for Biophotonics Technologies
  • Shifts towards Minimally Invasive Procedures Impacts the Market
  • Increasing Focus on Biomedical Research Spur Market Growth
  • Adoption of Biophotonics in Telemedicine and Remote Diagnostics Expands Usage of Technologies
  • Growing Awareness about Biophotonics Propel Market Demand
  • Rising Investment in Healthcare and Biotechnology Innovations Strengthens the Business Case for Biophotonics
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Biophotonics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Biophotonics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Biophotonics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 4: World 16-Year Perspective for Biophotonics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for See-through Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 6: World Historic Review for See-through Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 7: World 16-Year Perspective for See-through Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Inside Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Inside Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 10: World 16-Year Perspective for Inside Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Spectro Molecular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Spectro Molecular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 13: World 16-Year Perspective for Spectro Molecular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Surface Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Surface Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 16: World 16-Year Perspective for Surface Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Microscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Microscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 19: World 16-Year Perspective for Microscopy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Light Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Light Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 22: World 16-Year Perspective for Light Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Biosensors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Biosensors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 25: World 16-Year Perspective for Biosensors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Tests & Components by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Tests & Components by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 28: World 16-Year Perspective for Tests & Components by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Medical Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Medical Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 31: World 16-Year Perspective for Medical Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Medical Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Medical Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 34: World 16-Year Perspective for Medical Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Non-Medical Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Non-Medical Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 37: World 16-Year Perspective for Non-Medical Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Non-Medical Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Non-Medical Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 40: World 16-Year Perspective for Non-Medical Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Biophotonics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 41: USA Recent Past, Current & Future Analysis for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 43: USA 16-Year Perspective for Biophotonics by Application - Percentage Breakdown of Value Sales for See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors for the Years 2014, 2024 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 46: USA 16-Year Perspective for Biophotonics by End-Use - Percentage Breakdown of Value Sales for Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications for the Years 2014, 2024 & 2030
• CANADA
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 49: Canada 16-Year Perspective for Biophotonics by Application - Percentage Breakdown of Value Sales for See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors for the Years 2014, 2024 & 2030
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 52: Canada 16-Year Perspective for Biophotonics by End-Use - Percentage Breakdown of Value Sales for Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications for the Years 2014, 2024 & 2030
• JAPAN
  • Biophotonics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 55: Japan 16-Year Perspective for Biophotonics by Application - Percentage Breakdown of Value Sales for See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors for the Years 2014, 2024 & 2030
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 58: Japan 16-Year Perspective for Biophotonics by End-Use - Percentage Breakdown of Value Sales for Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications for the Years 2014, 2024 & 2030
• CHINA
  • Biophotonics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 59: China Recent Past, Current & Future Analysis for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 61: China 16-Year Perspective for Biophotonics by Application - Percentage Breakdown of Value Sales for See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors for the Years 2014, 2024 & 2030
  • TABLE 62: China Recent Past, Current & Future Analysis for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 64: China 16-Year Perspective for Biophotonics by End-Use - Percentage Breakdown of Value Sales for Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications for the Years 2014, 2024 & 2030
• EUROPE
  • Biophotonics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 65: Europe Recent Past, Current & Future Analysis for Biophotonics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 66: Europe Historic Review for Biophotonics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 67: Europe 16-Year Perspective for Biophotonics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 70: Europe 16-Year Perspective for Biophotonics by Application - Percentage Breakdown of Value Sales for See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors for the Years 2014, 2024 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 73: Europe 16-Year Perspective for Biophotonics by End-Use - Percentage Breakdown of Value Sales for Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications for the Years 2014, 2024 & 2030
• FRANCE
  • Biophotonics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 74: France Recent Past, Current & Future Analysis for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 75: France Historic Review for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 76: France 16-Year Perspective for Biophotonics by Application - Percentage Breakdown of Value Sales for See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors for the Years 2014, 2024 & 2030
  • TABLE 77: France Recent Past, Current & Future Analysis for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 78: France Historic Review for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 79: France 16-Year Perspective for Biophotonics by End-Use - Percentage Breakdown of Value Sales for Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications for the Years 2014, 2024 & 2030
• GERMANY
  • Biophotonics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 80: Germany Recent Past, Current & Future Analysis for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 81: Germany Historic Review for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 82: Germany 16-Year Perspective for Biophotonics by Application - Percentage Breakdown of Value Sales for See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors for the Years 2014, 2024 & 2030
  • TABLE 83: Germany Recent Past, Current & Future Analysis for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 84: Germany Historic Review for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 85: Germany 16-Year Perspective for Biophotonics by End-Use - Percentage Breakdown of Value Sales for Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications for the Years 2014, 2024 & 2030
• ITALY
  • TABLE 86: Italy Recent Past, Current & Future Analysis for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 87: Italy Historic Review for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 88: Italy 16-Year Perspective for Biophotonics by Application - Percentage Breakdown of Value Sales for See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors for the Years 2014, 2024 & 2030
  • TABLE 89: Italy Recent Past, Current & Future Analysis for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 90: Italy Historic Review for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 91: Italy 16-Year Perspective for Biophotonics by End-Use - Percentage Breakdown of Value Sales for Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications for the Years 2014, 2024 & 2030
• UNITED KINGDOM
  • Biophotonics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 92: UK Recent Past, Current & Future Analysis for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 93: UK Historic Review for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 94: UK 16-Year Perspective for Biophotonics by Application - Percentage Breakdown of Value Sales for See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors for the Years 2014, 2024 & 2030
  • TABLE 95: UK Recent Past, Current & Future Analysis for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 96: UK Historic Review for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 97: UK 16-Year Perspective for Biophotonics by End-Use - Percentage Breakdown of Value Sales for Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications for the Years 2014, 2024 & 2030
• REST OF EUROPE
  • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 99: Rest of Europe Historic Review for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 100: Rest of Europe 16-Year Perspective for Biophotonics by Application - Percentage Breakdown of Value Sales for See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors for the Years 2014, 2024 & 2030
  • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 102: Rest of Europe Historic Review for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 103: Rest of Europe 16-Year Perspective for Biophotonics by End-Use - Percentage Breakdown of Value Sales for Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications for the Years 2014, 2024 & 2030
• ASIA-PACIFIC
  • Biophotonics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 105: Asia-Pacific Historic Review for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 106: Asia-Pacific 16-Year Perspective for Biophotonics by Application - Percentage Breakdown of Value Sales for See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors for the Years 2014, 2024 & 2030
  • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 108: Asia-Pacific Historic Review for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 109: Asia-Pacific 16-Year Perspective for Biophotonics by End-Use - Percentage Breakdown of Value Sales for Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications for the Years 2014, 2024 & 2030
• REST OF WORLD
  • TABLE 110: Rest of World Recent Past, Current & Future Analysis for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 111: Rest of World Historic Review for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 112: Rest of World 16-Year Perspective for Biophotonics by Application - Percentage Breakdown of Value Sales for See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors for the Years 2014, 2024 & 2030
  • TABLE 113: Rest of World Recent Past, Current & Future Analysis for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 114: Rest of World Historic Review for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 115: Rest of World 16-Year Perspective for Biophotonics by End-Use - Percentage Breakdown of Value Sales for Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications for the Years 2014, 2024 & 2030

IV. COMPETITION